U.S. markets closed

Pressure BioSciences, Inc. (PBIO)

Other OTC - Other OTC Precio retrasado. Divisa en USD.
Añadir a la lista de seguimiento
0.2410+0.0068 (+2.93%)
Al cierre: 03:41PM EDT

Pressure BioSciences, Inc.

14 Norfolk Avenue
South Easton, MA 02375
United States
508 230 1828
https://www.pressurebiosciences.com

Sector(es)Healthcare
IndustriaMedical Devices
Empleados a tiempo completo16

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Richard T. SchumacherFounder, President, CEO, Treasurer, Interim CFO, Clerk & Director320.54kN/D1950
Dr. Edmund Y. Ting Ph.D., Sc.D. Ph.D.Senior Vice President of Engineering215.16kN/D1955
Dr. Alexander V. Lazarev Ph.D.Vice President of Research & Development202.27kN/D1965
John B. HollisterDirector of Sales & MarketingN/DN/DN/D
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. The company was incorporated in 1978 and is based in South Easton, Massachusetts.

Gestión corporativa

La calificación ISS Governance QuickScore de Pressure BioSciences, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.